The Venture Codex

Led · Series A · Jul 2026

Healia builds a benefits platform and a Total Care Option (TCO) that compares household plan options and enables employers to reimburse families' out-of-pocket costs and premiums when they enroll in a spouse's plan. The TCO prices every path for a household, manages claims, and reimburses copays, coinsurance, deductibles, or premiums in a matter of hours. Employers using Healia have provided $33 million in additional coverage since the company's 2021 founding, and Healia says enrolled households can save up to $26,000 a year while employers can lower spend up to 76% per enrolled household. The company emphasizes operations and technology to deliver decision support and claims management. Healia plans to expand its teams in sales, engineering, and operations and to invest further in the AI and technology behind the TCO.

Led · Series B · Jan 2026

Canopy is a San Francisco–based company delivering a connected safety platform for U.S. health systems. Its proprietary Location ID network supplies hospitals with real-time situational awareness, spanning discreet duress alerts for staff, asset management, and workflow optimization. The system flags security or clinical red alerts and enables faster response times, safeguarding frontline personnel. To date, Canopy says it has protected more than 300,000 healthcare workers across 60 major health systems and has been deployed in over 1,200 buildings. The company is preparing to release two new modules—Canopy Find and Canopy Track—to further boost operational efficiency and patient experience. Proceeds from its latest financing will fund nationwide expansion so every healthcare worker can access its safety tools. The firm is led by CEO and co-founder Shan Sinha, and recently added experienced healthcare executive Bharat Sundaram to its board to support scaling efforts.

Participated · Series B · Jan 2025

KODE operates an on-demand marketplace and the KODE Management Platform that connects hospitals and providers to a community of certified medical coders (“Koders”) while combining AI-driven tools with human expertise. The platform is designed to accelerate collections and reduce staffing costs by addressing inefficiencies in traditional medical coding workflows. KODE plans to expand its network of certified coding professionals and further develop AI and predictive-analytics capabilities to move beyond staffing into technology-first revenue cycle solutions. The company reports coding over a quarter million medical records per month and a community of more than 5,500 certified coding professionals who have coded over 8 million records to date. KODE says it has achieved consistent operational profitability. The product roadmap emphasizes additional investment in product development, platform enhancements, and scaling its team of Koders.

Led · Series B · Aug 2022

Arine operates an AI-driven medication optimization platform that delivers scalable, personalized medication therapy recommendations to health plans and risk-bearing providers. The platform leverages large, diverse datasets to identify the right individuals, recommend effective interventions, and continuously measure impact. Arine reports outcomes including >10% total cost savings and >40% reduction in hospitalizations, and it experienced >100% growth last year with average contract expansion of 80% with existing clients. The company focuses on improving medication safety, adherence, and effectiveness across populations, including underserved communities. With new funding, Arine plans to expand specialty pharmacy management, accelerate AI innovation to automate high-volume, low-complexity tasks, and integrate additional data to further personalize medication therapy. Arine is a medication intelligence startup that uses its platform to help health plans reduce medication errors, avoid complications, and keep patients out of the hospital. The company serves health plans and risk-bearing providers by improving medication safety and lowering cost of care. Founded in 2017 and based in San Francisco, Arine provides technology to enable better clinical and financial outcomes around medications. Arine plans to use the new funding to advance its platform capabilities to enable value-based care at scale. It intends to expand offerings beyond health plans and providers to other channel partners across the value-based care continuum. The company raised the financing as a mix of equity and debt to support that product and market expansion. Arine is an AI-driven platform that optimizes medication management for health plans and providers. The platform intakes clinical, social, and behavioral data and uses thousands of algorithms to recommend just-in-time clinical interventions for each patient. Those timely interventions are intended to reduce the total cost of care and drive a significant ROI, and the company states it saves one in every six healthcare dollars spent. Arine currently actively manages 5.5M lives. The company plans to use new funding to rapidly scale its team and its technology platform. Its product enables clinicians to provide personalized care by creating a whole picture of each patient based on multi-source data.

Participated · Series B · Feb 2022

Codoxo offers a Generative AI-powered Unified Cost Containment Platform that spans the entire claim lifecycle, with its flagship Point Zero Payment Integrity model intervening before claims are even submitted. By combining proactive provider education, data mining, clinical chart review, deepfake detection, and policy-to-code automation, the platform reduces downstream denials and overpayments while strengthening payer–provider relationships. The company supports payment integrity operations across more than 80 million covered lives and reports 100 % customer retention and 125 % net revenue retention for 2025. Customer implementations have delivered $12–$16 PMPY in savings at the pre-claim stage and up to $66 PMPY across the broader payment spectrum. Codoxo has earned recognition from Inc. 5000, Everest Group, Black Book Research, and the A.I. Awards, underscoring its category leadership. Recent product launches include the Data Health Integrity Agent and generative-AI-driven Policy-to-Code capabilities. With continued compliance achievements such as NIST 800-53 Rev 5 and HITRUST r2 certification, Codoxo is positioning itself for accelerated national expansion.